<sentence id="0">Role of glycosylation in conformational stability , activity , macromolecular interaction and immunogenicity of recombinant human factor VIII .</sentence>
<sentence id="1">Factor VIII ( FVIII ) is a multi-domain glycoprotein that is an essential cofactor in the blood coagulation cascade .</sentence>
<sentence id="2">Its deficiency or dysfunction causes hemophilia A , a bleeding disorder .</sentence>
<sentence id="3">Replacement using exogenous recombinant human factor VIII ( rFVIII ) is the first line of therapy for hemophilia A. <scope type="spec" id="0"> The role of glycosylation on the activity , stability , protein-lipid interaction , and immunogenicity of FVIII is <cue type="spec" id="0">not known</cue></scope> .</sentence>
<sentence id="4">In order to investigate the role of glycosylation , a deglycosylated form of FVIII was generated by enzymatic cleavage of carbohydrate chains .</sentence>
<sentence id="5">The biochemical properties of fully glycosylated and completely deglycosylated forms of rFVIII ( degly rFVIII ) were compared using enzyme-linked immunosorbent assay , size exclusion chromatography , and clotting activity studies .</sentence>
<sentence id="6">The biological activity of degly FVIII decreased in comparison to the fully glycosylated protein .</sentence>
<sentence id="7">The ability of degly rFVIII to interact with phosphatidylserine containing membranes was partly impaired .</sentence>
<sentence id="8">Data <scope type="spec" id="1"> <cue type="spec" id="1">suggested</cue> that glycosylation significantly influences the stability and the biologically relevant macromolecular interactions of FVIII</scope> .</sentence>
<sentence id="9">The effect of glycosylation on immunogenicity was investigated in a murine model of hemophilia A. Studies showed that deletion of glycosylation did <scope type="neg" id="2"><cue type="neg" id="2">not</cue> increase immunogenicity</scope> .</sentence>